A SYSTEMATIC REVIEW OF INFECTION CONTROL MEASURES IN BLOOD DISORDER TREATMENT CENTERS
DOI:
https://doi.org/10.48047/Keywords:
antimicrobial resistance, blood culture, Europe, faecal microbiota transplantation, hematology, infection control, pathogen reductionAbstract
Background: Infection control is critical in hematology units as patients with blood disorders are highly vulnerable to acquiring healthcare-associated infections. The increased risk of infection is high due to the nature of various immunosuppressive treatments, including chemotherapy, bone marrow transplantation, and CAR-T cell therapy.
Objective: This systematic review assesses European blood disorder treatment facilities through evidence evaluation and synthesis regarding their infection control measures as they impact patient safety and intervention outcomes.
Methods: A systematic review followed the PRISMA 2020 guidelines throughout its conduct. The PubMed database served as the primary information source for our research in February 2025. The research used "infection control" alongside "blood disorders" and "hematology" as search parameters, along with names of particular European nations. Researchers included studies based on infection control interventions that targeted hematology or transfusion settings between 2010 and 2024. The authors extracted key information regarding study design, intervention type, patient data, implementation obstacles, and measured outcomes.
Results: The research analysis included eight eligible studies involving expert consensus guidelines, observational analyses, and modeling studies. The study identified pathogen reduction technologies (PRTs) and HEV screening as well as blood culture standardization and antimicrobial resistance (AMR) surveillance and infection prophylaxis in CAR-T cell therapy and fecal microbiota transplantation (FMT) safety among the infection control strategies. Multiple research studies found that effective infection reduction methods and improved diagnostics were successful, yet variations existed between national guideline practice and monitoring programs.
Conclusions: European healthcare institutions for hematology patients show an increasing tendency towards implementing proactive, evidence-based infection control practices. High-quality guidelines and modern technologies remain accessible, but differences emerge during implementation. The region requires coordinated efforts to standardize healthcare practices while improving screening mechanisms and funding distribution to protect patients equitably on an equal basis.
Downloads
References
Böll, B., Schalk, E., Buchheidt, D., Hasenkamp, J., Kiehl, M., Kiderlen, T. R., ... & Hentrich, M. (2021). Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Annals of hematology, 100, 239-259.
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., ... & Gasbarrini, A. (2017). European Consensus conference on faecal microbiota transplantation in clinical practice. Gut, 66(4), 569-580.
Cassini, A., Högberg, L. D., Plachouras, D., Quattrocchi, A., Hoxha, A., Simonsen, G. S., ... & Hopkins, S. (2019). Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. The Lancet infectious diseases, 19(1), 56-66.
Chindelevitch, L., Jauneikaite, E., Wheeler, N. E., Allel, K., Ansiri-Asafoakaa, B. Y., Awuah, W. A., ... & van Dongen, M. (2022). Applying data technologies to combat AMR: current status, challenges, and opportunities on the way forward. arXiv preprint arXiv:2208.04683.
Clarke, H., Harrison, S., Perez, M. J., & Kirkman-Brown, J. (2021). UK guidelines for the medical and laboratory procurement and use of sperm, oocyte and embryo donors (2019). Human Fertility, 24(1), 3-13.
Denner, J., Pischke, S., Steinmann, E., Blümel, J., & Glebe, D. (2019). Why all blood donations should be tested for hepatitis E virus (HEV). BMC Infectious Diseases, 19, 1-5.
Domanović, D., Tedder, R., Blümel, J., Zaaijer, H., Gallian, P., Niederhauser, C., ... & Hewitt, P. (2017). Hepatitis E and blood donation safety in selected European countries: a shift to screening?. Eurosurveillance, 22(16), 30514.
Domanović, D., Ushiro-Lumb, I., Compernolle, V., Brusin, S., Funk, M., Gallian, P., ... & Rebulla, P. (2019). Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting. Blood transfusion, 17(6), 433.
Du, X., Tang, L., Wang, H., Yan, L., Wang, L., He, W., ... & Song, C. (2025). Compliance with standard precautions among hematology nurses: A cross-sectional study. American Journal of Infection Control, 53(4), 440-447.
Elliott, E. A. (2023). It Is Not You; It Is Me: A Mixed Method Phenomenological Study of Plasma Center Processes That Cause Inconsistent Donor Behavior (Doctoral dissertation, Northcentral University).
Engert, A., Balduini, C., Brand, A., Coiffier, B., Cordonnier, C., Döhner, H., ... & Schuringa, J. J. (2016). The European hematology association roadmap for European hematology research: a consensus document. haematologica, 101(2), 115.
Gupta, S., Rajiah, P., Middlebrooks, E. H., Baruah, D., Carter, B. W., Burton, K. R., ... & Miller, M. M. (2018). Systematic review of the literature: best practices. Academic radiology, 25(11), 1481-1490.
Hayden, P. J., Roddie, C., Bader, P., Basak, G. W., Bonig, H., Bonini, C., ... & Yakoub-Agha, I. (2022). Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of oncology, 33(3), 259-275.
Jangid, J., & Dixit, S. (2023). The Ai Renaissance: Innovations, Ethics, and the Future of Intelligent Systems. Ethics, and the Future of Intelligent Systems (December 01, 2023).
Jangid, J. (2020). Efficient Training Data Caching for Deep Learning in Edge Computing Networks. International Journal of Scientific Research in Computer Science, Engineering and Information Technology (IJSRCSEIT), ISSN, 2456-3307.
Jowett, M., Dale, E., Griekspoor, A., Kabaniha, G., Mataria, A., Bertone, M. P., & Witter, S. (2020). Health financing policy & implementation in fragile & conflict-affected settings: a synthesis of evidence and policy recommendations.
Lamy, B., Dargère, S., Arendrup, M. C., Parienti, J. J., & Tattevin, P. (2016). How to optimize the use of blood cultures to diagnose bloodstream infections? A state-of-the art. Frontiers in microbiology, 7, 697.
Mikulska, M. (2019). Infection control and isolation procedures. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies, 189-195.
Obeagu, E. I., & Adias, T. C. (2024). HIV and Transfusion Medicine: Insights into Donor Screening and Blood Safety. Lifeline Haematol, 2, 7-15.
Ombelet, S., Ronat, J. B., Walsh, T., Yansouni, C. P., Cox, J., Vlieghe, E., ... & Kane, A. A. (2018). Clinical bacteriology in low-resource settings: today's solutions. The Lancet Infectious Diseases, 18(8), e248-e258.
Sankar, V., & Villa, A. (2021). Hematologic diseases. Burket's Oral Medicine, 627-664.
Sanz, M. A., Fenaux, P., Tallman, M. S., Estey, E. H., Löwenberg, B., Naoe, T., ... & Lo-Coco, F. (2019). Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood, The Journal of the American Society of Hematology, 133(15), 1630-1643.
Sharma, G., & Chadha, P. (2023). Evaluation of haematological, genotoxic, cytotoxic and ATR-FTIR alterations in blood cells of fish Channa punctatus after acute exposure of aniline. Scientific Reports, 13(1), 20757.
Shiu, E. Y., Leung, N. H., & Cowling, B. J. (2019). Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention. Current opinion in infectious diseases, 32(4), 372-379.
Sovacool, B. K., Axsen, J., & Sorrell, S. (2018). Promoting novelty, rigor, and style in energy social science: Towards codes of practice for appropriate methods and research design. Energy research & social science, 45, 12-42.
Tacconelli, E., Sifakis, F., Harbarth, S., Schrijver, R., van Mourik, M., Voss, A., ... & Wolkewitz, M. (2018). Surveillance for control of antimicrobial resistance. The Lancet Infectious Diseases, 18(3), e99-e106.
Terveer, E. M., Van Beurden, Y. H., Goorhuis, A., Mulder, C. J. J., Kuijper, E. J., & Keller, J. J. (2017). Faecal microbiota transplantation in clinical practice. Gut, gutjnl-2017.
Tshibangu-Kabamba, E., & Yamaoka, Y. (2021). Helicobacter pylori infection and antibiotic resistance—from biology to clinical implications. Nature Reviews Gastroenterology & Hepatology, 18(9), 613-629.
Yakoub-Agha, I., Chabannon, C., Bader, P., Basak, G. W., Bonig, H., Ciceri, F., ... & Kröger, N. (2019). Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). haematologica, 105(2), 297.
Zjajo, A. (2024). The Influence of Antimicrobial Stewardship Measures on Outcome of Patients with Severe Infections treated in Intensive Care Unit (Doctoral dissertation, University of Zagreb. School of Medicine. Department of Infectious Diseases).
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Pavani Kottapalli, Beluri Talari Ranjith Kumar (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
